Isupetasys (007660) - Net Assets
Based on the latest financial reports, Isupetasys (007660) has net assets worth ₩756.20 Billion KRW (≈ $512.46 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩1.29 Trillion ≈ $873.88 Million USD) and total liabilities (₩533.31 Billion ≈ $361.42 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check tangible equity quality of Isupetasys to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩756.20 Billion |
| % of Total Assets | 58.64% |
| Annual Growth Rate | 9.72% |
| 5-Year Change | 502.59% |
| 10-Year Change | 281.78% |
| Growth Volatility | 37.97 |
Isupetasys - Net Assets Trend (2002–2025)
This chart illustrates how Isupetasys's net assets have evolved over time, based on quarterly financial data. See Isupetasys (007660) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Isupetasys (2002–2025)
The table below shows the annual net assets of Isupetasys from 2002 to 2025. For live valuation and market cap data, see 007660 market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ₩756.20 Billion ≈ $512.46 Million |
+130.88% |
| 2024-12-31 | ₩327.53 Billion ≈ $221.96 Million |
+22.77% |
| 2023-12-31 | ₩266.78 Billion ≈ $180.79 Million |
+19.99% |
| 2022-12-31 | ₩222.33 Billion ≈ $150.67 Million |
+77.17% |
| 2021-12-31 | ₩125.49 Billion ≈ $85.04 Million |
+92.74% |
| 2020-12-31 | ₩65.11 Billion ≈ $44.12 Million |
-14.36% |
| 2019-12-31 | ₩76.02 Billion ≈ $51.52 Million |
-57.21% |
| 2018-12-31 | ₩177.66 Billion ≈ $120.39 Million |
+2.62% |
| 2017-12-31 | ₩173.12 Billion ≈ $117.32 Million |
-12.60% |
| 2016-12-31 | ₩198.07 Billion ≈ $134.23 Million |
-0.02% |
| 2015-12-31 | ₩198.12 Billion ≈ $134.26 Million |
-0.26% |
| 2014-12-31 | ₩198.63 Billion ≈ $134.61 Million |
-4.19% |
| 2013-12-31 | ₩207.32 Billion ≈ $140.50 Million |
+22.89% |
| 2012-12-31 | ₩168.70 Billion ≈ $114.33 Million |
+3.94% |
| 2011-12-31 | ₩162.31 Billion ≈ $109.99 Million |
-0.59% |
| 2010-12-31 | ₩163.27 Billion ≈ $110.64 Million |
+20.66% |
| 2009-12-31 | ₩135.31 Billion ≈ $91.70 Million |
+32.03% |
| 2008-12-31 | ₩102.49 Billion ≈ $69.46 Million |
+11.81% |
| 2007-12-31 | ₩91.66 Billion ≈ $62.12 Million |
-1.14% |
| 2006-12-31 | ₩92.72 Billion ≈ $62.83 Million |
-6.08% |
| 2005-12-31 | ₩98.72 Billion ≈ $66.90 Million |
+8.87% |
| 2004-12-31 | ₩90.67 Billion ≈ $61.45 Million |
+2.99% |
| 2003-12-31 | ₩88.04 Billion ≈ $59.67 Million |
-1.59% |
| 2002-12-31 | ₩89.46 Billion ≈ $60.63 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Isupetasys's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 32577774947000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩325.78 Billion | 43.12% |
| Other Components | ₩429.72 Billion | 56.88% |
| Total Equity | ₩755.50 Billion | 100.00% |
Isupetasys Competitors by Market Cap
The table below lists competitors of Isupetasys ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Huaibei Mining Holdings Co Ltd
SHG:600985
|
$6.12 Billion |
|
YTL Corporation Bhd
KLSE:4677
|
$6.12 Billion |
|
Chemed Corp
NYSE:CHE
|
$6.12 Billion |
|
PGE Polska Grupa Energetyczna SA
WAR:PGE
|
$6.13 Billion |
|
Magyar Telekom Távközlési Nyilvánosan Müködö Részvénytársaság
F:MGYB
|
$6.11 Billion |
|
MERUS N.V. EO -09
F:2GH
|
$6.11 Billion |
|
TCL Zhonghuan Renewable Energy Technology Co Ltd
SHE:002129
|
$6.11 Billion |
|
Centessa Pharmaceuticals PLC ADR
NASDAQ:CNTA
|
$6.10 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Isupetasys's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 327,526,708,410 to 755,497,178,240, a change of 427,970,469,830 (130.7%).
- Net income of 160,481,952,830 contributed positively to equity growth.
- Dividend payments of 9,486,962,850 reduced retained earnings.
- New share issuances of 280,788,951,850 increased equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩160.48 Billion | +21.24% |
| Dividends Paid | ₩9.49 Billion | -1.26% |
| Share Issuances | ₩280.79 Billion | +37.17% |
| Other Changes | ₩-3.81 Billion | -0.5% |
| Total Change | ₩- | 130.67% |
Book Value vs Market Value Analysis
This analysis compares Isupetasys's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 11.95x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 28.06x to 11.95x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | ₩4383.29 | ₩123000.00 | x |
| 2018-12-31 | ₩4465.72 | ₩123000.00 | x |
| 2019-12-31 | ₩1911.78 | ₩123000.00 | x |
| 2020-12-31 | ₩1577.69 | ₩123000.00 | x |
| 2021-12-31 | ₩1984.17 | ₩123000.00 | x |
| 2022-12-31 | ₩3515.27 | ₩123000.00 | x |
| 2023-12-31 | ₩4218.08 | ₩123000.00 | x |
| 2024-12-31 | ₩5039.25 | ₩123000.00 | x |
| 2025-12-31 | ₩10291.58 | ₩123000.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Isupetasys utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 21.24%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 14.75%
- • Asset Turnover: 0.84x
- • Equity Multiplier: 1.71x
- Recent ROE (21.24%) is above the historical average (2.49%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 3.89% | 2.58% | 0.95x | 1.59x | ₩-5.47 Billion |
| 2003 | 0.02% | 0.01% | 1.01x | 1.67x | ₩-8.79 Billion |
| 2004 | 7.65% | 4.08% | 1.20x | 1.56x | ₩-2.13 Billion |
| 2005 | 3.01% | 1.87% | 0.94x | 1.72x | ₩-6.88 Billion |
| 2008 | 10.95% | 3.95% | 1.10x | 2.51x | ₩959.63 Million |
| 2009 | 13.33% | 6.04% | 1.09x | 2.02x | ₩4.41 Billion |
| 2010 | 15.10% | 7.12% | 1.12x | 1.89x | ₩8.10 Billion |
| 2011 | 4.94% | 2.02% | 1.17x | 2.09x | ₩-8.01 Billion |
| 2012 | 12.06% | 4.86% | 1.23x | 2.02x | ₩3.47 Billion |
| 2013 | 16.75% | 6.24% | 1.15x | 2.34x | ₩13.46 Billion |
| 2014 | 4.86% | 1.90% | 0.97x | 2.64x | ₩-10.17 Billion |
| 2015 | 7.94% | 3.00% | 1.03x | 2.57x | ₩-4.04 Billion |
| 2016 | 1.88% | 0.67% | 1.01x | 2.79x | ₩-16.04 Billion |
| 2017 | -8.14% | -2.64% | 1.10x | 2.80x | ₩-31.32 Billion |
| 2018 | -3.81% | -1.21% | 1.11x | 2.85x | ₩-24.53 Billion |
| 2019 | -119.83% | -17.72% | 1.23x | 5.48x | ₩-98.70 Billion |
| 2020 | -20.74% | -2.63% | 1.32x | 5.98x | ₩-20.02 Billion |
| 2021 | -2.87% | -0.77% | 1.04x | 3.58x | ₩-16.15 Billion |
| 2022 | 46.09% | 15.94% | 1.18x | 2.46x | ₩80.24 Billion |
| 2023 | 17.89% | 7.07% | 1.08x | 2.35x | ₩21.05 Billion |
| 2024 | 22.60% | 8.85% | 1.06x | 2.41x | ₩41.28 Billion |
| 2025 | 21.24% | 14.75% | 0.84x | 1.71x | ₩84.93 Billion |
Industry Comparison
This section compares Isupetasys's net assets metrics with peer companies in the Electronic Components industry.
Industry Context
- Industry: Electronic Components
- Average net assets among peers: $295,967,048,981
- Average return on equity (ROE) among peers: 6.00%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Isupetasys (007660) | ₩756.20 Billion | 3.89% | 0.71x | $6.12 Billion |
| YoungPoong (000670) | $1.28 Trillion | 11.22% | 0.60x | $608.86 Million |
| Sam Hwa Capaci (001820) | $44.73 Billion | 26.68% | 1.13x | $1.03 Billion |
| Samick Music I (002450) | $115.15 Billion | 2.75% | 0.74x | $66.31 Million |
| Hansol Technics (004710) | $52.45 Billion | 0.45% | 3.58x | $251.24 Million |
| Sunny Elec (004770) | $38.29 Billion | 2.70% | 0.05x | $40.33 Million |
| Samyoung Elec (005680) | $437.17 Billion | 2.95% | 0.07x | $181.58 Million |
| PJ Electronics Co. Ltd (006140) | $100.53 Billion | 5.88% | 0.19x | $50.87 Million |
| Korea Circuit Co. Ltd. (007810) | $195.34 Billion | 0.40% | 0.85x | $2.14 Billion |
| Korea Circuit Co Ltd (007815) | $398.77 Billion | 0.99% | 0.32x | $60.07 Million |
About Isupetasys
ISU Petasys Co., Ltd. manufactures and sells printed circuit boards (PCBs). The company offers network equipment, including router/switch and backplane; server/storage PCB; supercomputer high-performance computing PCB; aerospace PCB; and IC testers, including probe card, load board, and burn-in board. It also provides advanced driver assistance system RF radar PCBs; and radio frequency (RF) PCBs.… Read more